Walgreens Boots Alliance Lowers Fiscal 2024 Adjusted EPS Guidance To $2.80-$2.95 From $3.20-$3.35 Vs. Consensus Of $3.22, Reflects Challenging Pharmacy Industry Trends And A Worse-than-expected U.S. Consumer Environment
Portfolio Pulse from Benzinga Newsdesk
Walgreens Boots Alliance has lowered its fiscal 2024 adjusted EPS guidance to $2.80-$2.95 from $3.20-$3.35, citing challenging pharmacy industry trends and a worse-than-expected U.S. consumer environment. The new guidance is below the consensus of $3.22.
June 27, 2024 | 11:05 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Walgreens Boots Alliance has revised its fiscal 2024 adjusted EPS guidance downward to $2.80-$2.95 from $3.20-$3.35, which is below the consensus estimate of $3.22. This reflects challenging trends in the pharmacy industry and a worse-than-expected U.S. consumer environment.
The downward revision in EPS guidance indicates that Walgreens is facing significant challenges in the pharmacy industry and a tougher U.S. consumer environment than anticipated. This is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100